Group One Trading
KALV

Group One Trading’s KalVista Pharmaceuticals KALV Stock Holding History

Group One Trading’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-300
Closed -$4.84K – 8181
2025
Q4 		$4.84K Sell
300
-600
-67% -$7.95K ﹤0.01% 7198
2025
Q3 		$11K Sell
900
-1,500
-63% -$20.7K ﹤0.01% 7113
2025
Q2 		$27.1K Sell
2,400
-58,200
-96% -$712K ﹤0.01% 6070
2025
Q1 		$699K Buy
60,600
+60,500
+60,500% +$617K ﹤0.01% 2778
2024
Q4 		$847 Buy
+100
New +$1.04K ﹤0.01% 6924
2024
Q3 		– Sell
-7,900
Closed -$93.1K – 6986
2024
Q2 		$93.1K Sell
7,900
-7,200
-48% -$84K ﹤0.01% 4019
2024
Q1 		$179K Sell
15,100
-106,700
-88% -$1.42M ﹤0.01% 3653
2023
Q4 		$1.49M Buy
121,800
+110,700
+997% +$1.01M ﹤0.01% 2102
2023
Q3 		$107K Buy
+11,100
New +$113K ﹤0.01% 4391
2023
Q1 		– Sell
-5,700
Closed -$38.5K – 7569
2022
Q4 		$38.5K Sell
5,700
-113,300
-95% -$607K ﹤0.01% 5190
2022
Q3 		$1.73M Buy
119,000
+16,700
+16% +$233K ﹤0.01% 2044
2022
Q2 		$1.01M Buy
102,300
+101,700
+16,950% +$1.12M ﹤0.01% 2752
2022
Q1 		$9K Buy
+600
New +$8.62K ﹤0.01% 7203
2021
Q4 		– Sell
-400
Closed -$7K – 8508
2021
Q3 		$7K Sell
400
-900
-69% -$18.2K ﹤0.01% 7634
2021
Q2 		$31K Sell
1,300
-300
-19% -$7.85K ﹤0.01% 6937
2021
Q1 		$41K Sell
1,600
-7,600
-83% -$200K ﹤0.01% 6362
2020
Q4 		$175K Buy
+9,200
New +$158K ﹤0.01% 4157

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's KALV Position: Q1 2026 in Review

Group One Trading sold out of KalVista Pharmaceuticals (KALV) in Q1 2026, closing a stake of 3,777 shares — an estimated $61K sold.

Group One Trading first reported a position in KALV in Q4 2020 and held it in 12 quarters. The position peaked at $171K in Q4 2024. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Group One Trading reported no remaining KalVista Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,777 KalVista Pharmaceuticals shares in Q1 2026, an estimated $61K.
  • Group One Trading first reported a position in KalVista Pharmaceuticals in Q4 2020 and held it in 12 quarters.
  • Group One Trading's KalVista Pharmaceuticals position peaked at $171K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.